down arrow

Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000YP4
CNY
1.24
0.06 (5.08%)

Nov 25

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
Why is Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 0.02%
  • The company has been able to generate a Return on Capital Employed (avg) of 0.02% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -9.16% and Operating profit at 20.13% over the last 5 years
3
With a fall in Net Sales of -19.57%, the company declared Very Negative results in Mar 25
  • The company has declared negative results for the last 2 consecutive quarters
  • The company has declared negative results in Dec 24 after 2 consecutive negative quarters
  • OPERATING CASH FLOW(Y) Lowest at CNY -1,202.35 MM
  • NET PROFIT(Q) At CNY -70.32 MM has Fallen at -567.95%
  • DEBT-EQUITY RATIO (HY) Highest at 86.92 %
4
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -87.27%, its profits have risen by 120.7% ; the PEG ratio of the company is 0.3
5
Underperformed the market in the last 1 year
  • Even though the market (China Shanghai Composite) has generated returns of 14.77% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -87.27% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
-87.27%
-1.50
58.12%
China Shanghai Composite
15.19%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-9.16%
EBIT Growth (5y)
20.13%
EBIT to Interest (avg)
-1.59
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.83
Sales to Capital Employed (avg)
0.55
Tax Ratio
21.64%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.02%
ROE (avg)
0.02%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
0.36
EV to EBIT
80.41
EV to EBITDA
30.79
EV to Capital Employed
0.65
EV to Sales
1.51
PEG Ratio
0.34
Dividend Yield
NA
ROCE (Latest)
0.81%
ROE (Latest)
0.89%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
ROCE(HY)

Highest at -0.28%

RAW MATERIAL COST(Y)

Fallen by -88.22% (YoY

-34What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY -1,202.35 MM

NET PROFIT(Q)

At CNY -70.32 MM has Fallen at -567.95%

DEBT-EQUITY RATIO (HY)

Highest at 86.92 %

NET SALES(Q)

Lowest at CNY 312.97 MM

INTEREST(Q)

At CNY 17.17 MM has Grown at inf%

CASH AND EQV(HY)

Lowest at CNY 1,320 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 0%

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.93%

OPERATING PROFIT(Q)

Lowest at CNY -60.77 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -19.42 %

PRE-TAX PROFIT(Q)

Lowest at CNY -73.12 MM

EPS(Q)

Lowest at CNY -0.1

Here's what is working for Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
Raw Material Cost
Fallen by -88.22% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
Net Sales
At CNY 312.97 MM has Fallen at -35.78%
over average net sales of the previous four periods of CNY 487.35 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit
At CNY -73.12 MM has Fallen at -690.95%
over average net sales of the previous four periods of CNY 12.37 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit
At CNY -70.32 MM has Fallen at -567.95%
over average net sales of the previous four periods of CNY 15.03 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow
Lowest at CNY -1,202.35 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales
Lowest at CNY 312.97 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term sales trend is very negative

Net Sales (CNY MM)

Interest
At CNY 17.17 MM has Grown at inf%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio
Highest at 86.92 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Profit
Lowest at CNY -60.77 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at -19.42 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at CNY -73.12 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

EPS
Lowest at CNY -0.1
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Cash and Eqv
Lowest at CNY 1,320 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio
Lowest at 0%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 0.93%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."